Pairnomix is recognized in the media for its vision of a new, highly-personalized approach to epilepsy intervention


A 2015 Medscape Medical News article from the American Epilepsy Society 69th Annual Meeting highlighted the company’s efforts to pair rare disease genomics and advanced analytics to help epilepsy patients better understand their disorder. CEO Matthew Fox explained how, within a laboratory setting, Pairnomix models and characterizes a known mutation, tests compounds on it and then reports that information back to a patient’s treating physician.

The article, “A Gene-Based Approach to Epilepsy Therapy” by Pauline Anderson, can be viewed in its entirety here.

(Note: Readers new to Medscape must go through a free, one-time only registration process to access the article, as well as all other Medscape content)